Literature DB >> 6874164

Platelet activating factor (PAF) induces the oxidative burst in macrophages.

H P Hartung, M J Parnham, J Winkelmann, W Englberger, U Hadding.   

Abstract

The response of guinea pig peritoneal macrophages to platelet activating factor (1-O-octadecyl-2-acetyl-sn-glycero-3-phosphoryl-choline) was examined. In Corynebacterium parvum induced macrophages, platelet activating factor, over a wide dose range (3.8 X 10(-5) to 3.8 X 10(-9)M) triggered the oxidative burst as indicated by increased luminol-dependent chemiluminescence and hydrogen peroxide release into culture supernatants. This effect of PAF was inhibited by superoxide dismutase and catalase. Resident macrophages exhibited only slight respiratory activity in response to platelet activating factor which could be increased by adding 1% gelatine to the medium. Activation of macrophages is a new biological effect exerted by platelet activating factor. In immuno-inflammatory reactions, cells capable of generating platelet activating factor may come into close contact with macrophages and by liberating this mediator cause them to release highly toxic oxygen species known to be microbicidal and cytocidal and able to produce vascular endothelial injury. Our findings lend further support to the view that platelet activating factor is a potent and rapid activator of physiological defence mechanisms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874164     DOI: 10.1016/0192-0561(83)90002-4

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  18 in total

1.  Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.

Authors:  M J Parnham; C Bittner; G Lambrecht
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

Review 2.  Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes.

Authors:  L Flohé
Journal:  Mol Cell Biochem       Date:  1988-12       Impact factor: 3.396

3.  Regulation of the macrophage oxidative burst by mediators: effects of inhibitors.

Authors:  M J Parnham; W Englberger
Journal:  Agents Actions       Date:  1985-03

4.  Cell surface antigens on the guinea-pig macrophage: identification by monoclonal antibodies and association with the activation state.

Authors:  U Mauer-Gross; D von Steldern; U Hadding; D Bitter-Suermann; R Burger
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

5.  Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes.

Authors:  G Lambrecht; M J Parnham
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

6.  Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB.

Authors:  J H Choi; W J Chung; S J Han; H B Lee; I W Choi; H K Lee; K Y Jang; D G Lee; S S Han; K H Park; S Y IM
Journal:  Inflammation       Date:  2000-10       Impact factor: 4.092

7.  Effects of CIS-19, a novel PAF receptor antagonist, on PAF-induced eosinophil recruitment and enhancement of superoxide anion generation in guinea-pigs.

Authors:  C M Teng; C H Lin; H P Kuo; F N Ko; H Ishii; T Ishikawa; I S Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

8.  Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.

Authors:  G O Till; M L Morganroth; R Kunkel; P A Ward
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

9.  The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.

Authors:  N C Turner; L J Wood; F M Burns; T Gueremy; J E Souness
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

10.  Activation of monocytes by interferon-gamma has no effect on the level or affinity of the nicotinamide adenine dinucleotide-phosphate oxidase and on agonist-dependent superoxide formation.

Authors:  M Thelen; M Wolf; M Baggiolini
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.